Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-26 @ 3:05 AM
NCT ID:
NCT02158520
Group ID:
EG000
Title:
Arm A (Bevacizumab and Nab-paclitaxel)
Description:
Patients receive bevacizumab 10mg/kg IV over 30-90 minutes on days 1 and 15 and nab-paclitaxel 150 mg/m\^2 IV over 30 minutes on days 1, 8, and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients experiencing progressive disease may cross-over to Arm B within 2-4 weeks.
Deaths Number Affected:
10
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
12
Other Number Affected:
11
Other Number At Risk:
12
Study:
NCT02158520
Results Section:
NCT02158520
Adverse Events Module:
NCT02158520